No headlines found.
No press releases found.
No news found.
The investment objective of the FT Vest U.S. Equity Max Buffer ETF - November (the "Fund") is to seek to provide investors with returns (before fees and expenses) that match the price return of the SPDR S&P 500 ETF (the "Underlying ETF") up to a predetermined upside cap while seeking to provide the maximum available buffer (before fees and expenses), against Underlying ETF losses over an approximate period of one year (the "Target Outcome Period"). Over the Target Outcome Period from November 18, 2024 through November 21, 2025, the Fund seeks to buffer against 100% of Underlying ETF losses and limit gains up to a predetermined upside cap of 7.50%. When the Fund's fees and expenses are taken into account, the cap is 6.64% and the buffer is 99.13%.
FT Vest US Equity Max Buffer ETF - November trades on the BATS stock market under the symbol NOVM.
As of September 1, 2026, NOVM stock price was flat at $34.15 with 6 million shares trading.
NOVM has a market cap of $28.17 million. This is considered a Sub-Micro Cap stock.
NOVM has underperformed the market in the last year with a return of +7.0%, while SPY returned +19.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NOVM shares. However, NOVM has outperformed the market in the last 3 month and 2 week periods, returning +1.4% and +0.2%, while SPY returned +1.0% and -1.4%, respectively. This indicates NOVM has been having a stronger performance recently.
NOVM support price is $34.09 and resistance is $34.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NOVM shares will trade within this expected range on the day.
